Live Oka/Merck Varicella Vaccine in Healthy Children: Further Clinical and Laboratory Assessment

JAMA: The Journal of the American Medical Association

Volumn 254, Issue 17, 1985, Pages 2435-2439

  Weibel, Robert E ^a   Kuter, Barbara J ^b   Neff, Beverly J ^b   Rothenberger, Carol A ^a   Fitzgerald, Alison J ^a   Connor, Karen A ^a   Morton, David ^b   McLean, Arlene A ^b   Scolnick, Edward M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE; VIRUS ANTIBODY; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; VIRUS VACCINE;

ADVERSE DRUG REACTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY PRODUCTION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD AND HEMOPOIETIC SYSTEM; CHILD; DRUG DOSE; DRUG EFFICACY; DRUG THERAPY; FEVER; HUMAN; INJECTION PAIN; INTOXICATION; MAJOR CLINICAL STUDY; PREVENTION; PRIORITY JOURNAL; RASH; SKIN TOXICITY; SUBCUTANEOUS DRUG ADMINISTRATION; THERAPY; THROMBOCYTOPENIA; VACCINATION; VARICELLA ZOSTER VIRUS; ARTICLE; BIOSYNTHESIS; BLOOD; CHICKENPOX; FEMALE; FOLLOW UP; IMMUNOLOGY; INFANT; MALE; PAIN; PRESCHOOL CHILD; THROMBOCYTE COUNT;

ALANINE TRANSAMINASE; ANTIBODIES, VIRAL; ASPARTATE AMINOTRANSFERASES; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; FOLLOW-UP STUDIES; HERPESVIRUS 3, HUMAN; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; PAIN; PLATELET COUNT; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0022149678     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1985.03360170075034     Document Type: Article

References (22)

1. Takahashi M, Otsuka T, Okuno Y, et al.: Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-1290.
2. Takahashi M: Workshop on Live Varicella Virus Vaccine. Dept of Health and Human Services, Public Health Service, and Food and Drug Administration, Sept 20, 1983, pp 111-122.
3. Asano Y, Nagai T, Miyata T, et al.: Long-term protective immunity of recipients of the Oka strain of live varicella vaccine. Pediatrics 1985;75:667-671.
4. Arbeter AM, Starr SE, Preblud SR, et al.: Varicella vaccine trials in healthy children: A summary of comparative and follow-up studies. AJDC 1984;138:434-438.
5. Weibel RE, Neff BJ, Kuter BJ, et al.: Live attenuated varicella virus vaccine: Efficacy trial in healthy children. N Engl J Med 1984;310:1409-1415.
6. Hochberger R, Tokarski P, Koranyi K, et al.: Varicella hepatitis in children, in Crocker JFS (ed): Reye's Syndrome II. New York, Grune & Stratton Inc, 1979, pp 69-75.
7. Thaler MM: Clinical and enzymatic indices of hepatic dysfunction, in Crocker JFS (ed): Reye's Syndrome II. New York, Grune & Stratton Inc, 1979, pp 115-138.
8. Feusner JH, Slichter SJ, Harker LA: Mechanisms of thrombocytopenia in varicella. Am J Hematol 1979;7:255-264.
9. Spicer TE, Rau JM: Purpura fulminans. Am J Med 1976;61:566-571.
10. Wittek AE, Arvin AM, Koropchak CM: Serum immunoglobulin A antibody to varicellazoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects. J Clin Microbiol 1983;18:1146-1149.
11. Bogger-Goren S, Baba K, Hurley P, et al.: Antibody responses to varicella-zoster virus after natural or vaccine induced infection. J Infect Dis 1982;146:260-265.
12. Gershon AA, Kalter ZG, Steinberg S: Detection of antibody to varicella-zoster virus by immune adherence hemagglutination. Proc Soc Exp Biol Med 1976;151:762-765.
13. Williams V, Gershon A, Brunell PA: Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis 1974;130:669-672.
14. Gershon AA, Krugman S: Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test. Pediatrics 1975;56:1005-1008.
15. Yamada A, Ogino S, Asano Y, et al.: Comparison of four serologic tests—complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination—for assay of antibody to varicella-zoster (V-Z) virus. Biken J 1979;22:55-60.
16. Zaia JA, Oxman MN: Antibody to varicella-zoster virus induced membrane antigen: Immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J Infect Dis 1977;136:519-530.
17. Weller TH: Varicella and herpes zoster, in Lennette EH, Schmidt NJ (eds): Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, ed 5. Washington, DC, American Public Health Association, 1979, p 383.
18. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959;22:719-748.
19. Tukey J, Ciminera J, Heyse J: Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 1985;41:295-301.
20. Behrman RE, Vaughan VC (eds): Nelson's Textbook of Pediatrics, ed 12. Philadelphia, WB Saunders Co, 1983, p 1248.
21. Hebert CN, Creasey SE, Nicholas RAJ, et al.: The evaluation of plaque count data in the estimation of viral concentration. J Biol Stand 1980;8:49-57.
22. Williams WJ, Beutler E, Erslev AJ, et al. (eds): Hematology, ed 3. New York, McGraw-Hill Book Co Inc, 1983, pp 1303, 1343.